These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16834834

  • 21. A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis.
    Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator Team.
    J Urol; 2003 Apr; 169(4):1401-5. PubMed ID: 12629372
    [Abstract] [Full Text] [Related]

  • 22. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
    Michael Hill C, Sindet-Pederson S, Seymour RA, Hawkesford JE, Coulthard P, Lamey PJ, Gerry Cowan C, Wickens M, Jeppsson L, Dean AD, Svensson O.
    Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
    Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ, Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group.
    JAMA; 2002 Jan 02; 287(1):64-71. PubMed ID: 11754710
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial.
    Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A.
    Rev Rhum Engl Ed; 1997 Dec 02; 64(12):825-34. PubMed ID: 9476272
    [Abstract] [Full Text] [Related]

  • 25. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
    Wolfe F, Zhao S, Pettitt D.
    J Rheumatol; 2004 Jun 02; 31(6):1143-51. PubMed ID: 15170928
    [Abstract] [Full Text] [Related]

  • 26. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.
    Ann Rheum Dis; 2008 Mar 02; 67(3):323-9. PubMed ID: 17616556
    [Abstract] [Full Text] [Related]

  • 27. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
    Cannon GW, Caldwell JR, Holt P, McLean B, Seidenberg B, Bolognese J, Ehrich E, Mukhopadhyay S, Daniels B.
    Arthritis Rheum; 2000 May 02; 43(5):978-87. PubMed ID: 10817549
    [Abstract] [Full Text] [Related]

  • 28. Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
    Weaver AL, Messner RP, Storms WW, Polis AB, Najarian DK, Petruschke RA, Geba GP, Tershakovec AM.
    J Clin Rheumatol; 2006 Feb 02; 12(1):17-25. PubMed ID: 16484875
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies.
    Bingham CO, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, Smugar SS, Fitzgerald BJ, O'Brien K, Tershakovec AM.
    Rheumatology (Oxford); 2007 Mar 02; 46(3):496-507. PubMed ID: 16936327
    [Abstract] [Full Text] [Related]

  • 30. A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes.
    Reuben SS, Buvenandran A, Katz B, Kroin JS.
    Anesth Analg; 2008 Apr 02; 106(4):1258-64, table of contents. PubMed ID: 18349203
    [Abstract] [Full Text] [Related]

  • 31. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
    Ehrich EW, Bolognese JA, Watson DJ, Kong SX.
    Am J Manag Care; 2001 Jun 02; 7(6):609-16. PubMed ID: 11439734
    [Abstract] [Full Text] [Related]

  • 32. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep 02; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
    Chelly JE, Nissen CW, Rodgers AJ, Smugar SS, Tershakovec AM.
    Curr Med Res Opin; 2007 Jan 02; 23(1):195-206. PubMed ID: 17207303
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ, Kivitz AJ, Lipetz RS, Sanders N, Hee A.
    Arthritis Rheum; 2005 Dec 15; 53(6):827-37. PubMed ID: 16342089
    [Abstract] [Full Text] [Related]

  • 36. Celecoxib 200 mg q.d. is efficacious in the management of osteoarthritis of the knee or hip regardless of the time of dosing.
    Stengaard-Pedersen K, Ekesbo R, Karvonen AL, Lyster M.
    Rheumatology (Oxford); 2004 May 15; 43(5):592-5. PubMed ID: 14762227
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
    Kivitz AJ, Greenwald MW, Cohen SB, Polis AB, Najarian DK, Dixon ME, Moidel RA, Green JA, Baraf HS, Petruschke RA, Matsumoto AK, Geba GP, Protocol 085 Study Investigators.
    J Am Geriatr Soc; 2004 May 15; 52(5):666-74. PubMed ID: 15086644
    [Abstract] [Full Text] [Related]

  • 38. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
    Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher HR, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williams HJ.
    N Engl J Med; 2006 Feb 23; 354(8):795-808. PubMed ID: 16495392
    [Abstract] [Full Text] [Related]

  • 39. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
    Soni P, Shell B, Cawkwell G, Li C, Ma H.
    Curr Med Res Opin; 2009 Aug 23; 25(8):1841-51. PubMed ID: 19530981
    [Abstract] [Full Text] [Related]

  • 40. Treatment of osteoarthritis with continuous versus intermittent celecoxib.
    Strand V, Simon LS, Dougados M, Sands GH, Bhadra P, Breazna A, Immitt J.
    J Rheumatol; 2011 Dec 23; 38(12):2625-34. PubMed ID: 22045833
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.